# Bicyclo 3.3.0 octane derivatives.

## Abstract
Bicyclo 3.3.0 octane derivatives of the formula

## Claims
CLAIMS FOR CONTRACTING STATES BE, CH DE, FR. GB. IT. LI. LU, NL, SE. 1. A compound of the general formula EMI62.1 wherein Ac represents an acetyl group, THP represents a tetrahydropyran 2 yl group and R represents a formyl group or a group of the general formula EMI62.2 in which one of R1 and R2 represents a hydroxy group and the other represents a hydrogen atom or R1 and R2 together represent an oxo group, R3 represents a single bond or a straight or branched chain alkylene group of 1 to 5 carbon atoms and R represents a straight or branched chain alkyl group of 1 to 8 carbon atoms, a straight . or branched chain alkenyl or alkynyl group of 2 to 8 carbon atoms, a cycloalkyl group of 4 to 7 carbon atoms either unsubstituted or substituted by at least one straight or branched chain alkyl group of 1 to 8 carbon atoms or represents a phenyl group or phenoxy group either unsubstituted or substituted by at least one halogen atom, trifluoromethyl group or straight or branched chain alkyl group of 1 to 4 carbon atoms, and the double bond in general formula VIII is E with the proviso that when R3 represents a single bond,R4 does not represent a substituted or unsubstituted phenoxy group . 2. A compound according to claim wherein R3 represents a single bond or a methylene or ethylene group. 3. A compound according to claim 2 wherein R4 represents a cycloalkyl group of 4 to 7 carbon atoms either unsubstituted or substituted by at least one straight or branched chain alkyl group of 1 to 8 carbon atoms. 4. A compound according to claim 1 wherein the grouping R3 R4 represents a cyclopentyl group. 5. A compound according to any one of the preceding claims wherein, in general formula VIIIidepicted in in claim 1, one of R1 and R2 represents a hydroxy group in aconfiguration and the other represents a hydrogen atom. 6. A compound according to claim 1 which is E 3aS acetoxy 6 syn 3 oxo 3 cyclopentylprop l enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3.3.01 octane. 7. A compound according to claim 1 which is E 3aS acetoxy 6 syn 3 hydroxy 3 cyclopentylprop 1 enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3,3.01 octane. 8. A process for the preparation of a compound according to claim 1, which comprises a the oxidation of a compound of the general formula EMI64.1 wherein Ac and THP are as defined in claim 1 to obtain a compound of the general formula EMI64.2 wherein Ac and THP are as defined in claim 1 , followed, if desired, by b the reaction of the compound of general formula VIIC, wherein THP and Ac are as defined in claim 1, with a sodiumderivative of a dialkyl phosphonate of the general formula EMI64.3 wherein R5 represents an alkyl group of 1 to 4 carbon atoms and the other symbols are as defined in claim 1 or with a phosphorane compound of the general formula EMI64.4 wherein R represents a phenyl group unsubstituted or substituted by at least one alkyl group of 1 to 4 carbon atoms or represents an alkyl group of 1 to 6 carbon atoms or represents a cyclohexyl group, and the other symbols are as defined in claim 1 to obtain a compound of the general formula EMI65.1 wherein the various symbols are as defined in claim 1 . followed, if desired, by c the reduction of a compound of the general formulaVIIB depicted in claim 9 wherein the various symbols are as defined in claim 1 to obtain a compound of the general formula EMI65.2 wherein the various symbols are as defined in claim 1. CLAIMS FOR CONTRACTING STATE AT 1. A process for the preparation of a compound of the general formula EMI66.1 wherein Ac represents an acetyl group, ThP represents a tetrahydropyran 2 yl group and R represents a formyl group or a group of the general formula EMI66.2 in which one of R1 and R2 represents a hydroxy group and the other represents a hydrogen atom, or R1 and R2 together represent an oxo group, R3 represents a single bond or a straight or branched chain alkylene group of 1 to 5 carbon atoms and R4 represents a straight or branched chain alkyl group of 1 to 8 carbon atoms, a straight or branched chain alkenyl or alkynyl group of 2 to 8 carbon atoms, a cycloalkyl group of 4 to 7 carbon atoms either unsubstituted or substitute by at least one straight or branched chain alkyl group of 1 to 8 carbon atoms or represents a phenyl group or phenoxy group either unsubstituted or substituted by at least one halogen atom, trifluoromethyl group or straightor branched chain alkyl group of 1 to 4 carbon atoms, and the double bond in general formula VIII is E with the proviso 3 when R3 represents a single bond, 4 that when R represents a single bond, R4 does not represent a subsituted or unsubsituted phenoxy group , which process comprises a the oxidation of a compound of the general formula EMI67.1 wherein Ac and THP are as hereinbefore defined to obtain a compound of the general formula EMI67.2 wherein Ac and THP are as hereinbefore defined followed, if desired, by b the reaction of a compound of general formula VIIC wherein T,Hp and Ac are as hereinbefore defined with a sodium derivative of a dialkyl phosphonate of the general formula EMI68.1 wherein R5 represents an alkyl group of 1 to 4 carbon atoms and the other symbols are as hereinbefore defined or with a phosphorane compound of the general formula EMI68.2 wherein R6 represents a phenyl group unsubstituted or substituted by at least one alkyl group of 1 to 4 carbon atoms or represents an alkyl group of 1 to 6 carbon atoms or represents a cyclohexyl group, and the other symbols are as hereinbefore defined to obtain a compound of the general formula EMI68.3 wherein the various symbols are as hereinbefore defined followed, if desired, by c the reduction of a compound of the general formulaVIIB wherein the various symbols are as hereinbefore defined to obtain a compound of the general formula EMI69.1 wherein the various symbols are as hereinbefore defined. 2. A process according to claim 1 wherein R3 represents a single bond or a methylene or ethylene group. 3. A process according to claim 2 wherein R4 represents a cycloalkyl group of 4 to 7 carbon atoms either unsubstituted or substituted by at least one straight or branched chain alkyl group of 1 to 8 carbon atoms. 4. A process according to claim 1 wherein the grouping R3 R4 represents a cyclopentyl group. 5. A process according to claim 1 wherein, in general formula VIIA, the hydroxy group attached to the 3 position is in a configuration.

## Description
BICYCLO 3.3.0 OCTANE DERIVATIVES This invention relates to new bicyclo 3.3.0 octane derivatives. More particularly, it relates to bicyclo 3.3.0 octane derivatives useful as important intermediates for the preparation of 6,9 methano PGI2 analogues, especially the 5E isomethereof, and to processes for the preparation thereof. 5E 6,9 rnethano PGI2 i.e. carbacyclin is a compound having the following structural formula EMI1.1 Carbacyclin has the same pharmacological properties asPGI2 has, and further has high stability as compared with PGI2, and, therefore, it expected to be developed as a medicine. There have been filed many patent applications relating to SE 6,9 rnethano PGI2 derivatives. In particular SE 15 cyclopentyl 16,17,18,19,20 penta 6,9 methano PGI2 having the following structural formula EMI2.1 has a potent inhibitory activity on platelet aggregation and an excellent protective activity on brain anoxia, and, therefore, may be useful in the treatment of circulatory diseases and in the treatment of anoxia of brain cells see British Patent No. 20176993 DerwentNo. 73954B and German Patent Application No. 3315356.6 . There have also been many proposals relating to processes for the preparation of 5E 6,9 methanoPGI2 and derivatives thereof. However, these processes are not necessarily advantageous for commercial massproduction, and there is still great room for improvement. In the preparation of 5E 6,9 methano PGI2 and derivatives thereof, the known processes which are generally used involve the introduction of upper and lower side chains into various specific bicyclo 3.3.0 octane derivatives represented, as a skeleton compound, by general formula III by using Wittig reactions as shown in the scheme below. Therefore, the bicyclot3.3.0 octane derivative of the formula III is considered to be a very important intermediate for the preparation of SE 6,9 methano PGI2 and derivatives thereof, and thus it is important to use a bicyclo 3.3.0 octane derivative of the formula III which permits good chemical yields to be obtained and allows ease of treatment in commercial mass production.The values of symbols X and Y which appear in the scheme are given in the following discussion of specific intermediates which have hitherto been described X represents various specific carbonylprotecting groups or groups which can be converted to introduce a carbonyl group, Y represents various specific hydroxy protecting groups and Z may represent a variety of substituents. It is to.be understood that not all compounds embraced generally by formula III are known the formula is used to represent certain specific known intermediate compounds which are defined and discussed in more detail hereinafter. Scheme EMI3.1 As bicyclot3.3.O octane derivatives of the formula III, several specific compounds which have various and different carbonyl protecting groups X and of hydroxy protecting groups Y , have been proposed. For example, in the specification of BritishPatent No. 2017699B Derwent No. 73954B , there is disclosed a process which comprises subjecting a compound of the formula EMI4.1 wherein represents a phenyl group to a first Wittig reaction to introduce a lower side chain, converting the acetoxy group attached to the 3 position into a hydroxy group and oxidising the hydroxy group produced to an oxb group to form a ketone, and then subjecting the compound obtained to a second Wittig reaction to introduce an upper side chain. Furthermore, it is disclosed that the compound of the formula IV may be prepared by oxidizing a compound of the formula EMI5.1 wherein pl is as hereinbefore defined. However, in such an oxidation particularly an oxidation using a base such as pyridine , it has been confirmed that a compound formed from the compound of the formula V by elimination of the benzoyl group at the 7 position to form a double bond between C6 and C7 positions is formed as by product in a high proportion of 10 50 . Therefore, it can not be said that the compound of the formula IV having a hydroxy group protected by a benzoyl group at the 7position, is an intermediate suitable for commercial mass production. In the specification of the European PatentPublication No. 11591 Derwent No. 32903C , there is disclosed a process which comprises subjecting a compound of the formula EMI5.2 wherein pl is as hereinbefore defined, to a first Wittig reaction to introduce a lower side chain, then cleaving the ketal to form a ketone. and then introducing an upper side chain by a similar reaction. Furthermore, it is described that the compound of the formula VI may be prepared by the series of reactions depicted below, wherein a is as hereinbefore defined SchemeEMI6.1 However, the catalyst presently used for the debenzylation reaction by hydrogenolysis, is generally palladium on carbon, but it is extremely dangerous to use a large quantity of palladium on carbon in commercial mass production. In addition, the ketal group protecting the ketone group is liable to be cleaved and there is a further possibility of the ketal being cleaved in the course of subsequent reaction steps. Another disadvantage is that the benzoyl group is cleaved in the oxidation step the hydroxy group at the 7 position is protected by a benzoyl group, as in the compound of the formula IV .From the above view point, the intermediate of the formulaVI also is not a compound suitable for commercial massproduction. In addition to the specific compounds mentioned above, various other intermediates of the formula III have been proposed see British Patent Publication Nos.2012265A Derwent No. 54825B , 2013661A Derwent No. 562903 , 2014143A Derwent No. 59839B and 2019847A Derwent No. 66338B , but all of them have some disadvantage from the view point of ease of use, chemical yield andcosts. A suitable intermediate should have protecting groups which are easily cleaved in a cleavage reaction but which otherwise remain attached and unaffected in other reactions and should not give rise to side reactions. As a result of research and experimentation to discover a novel intermediate of the formula III which may be converted to a desired 5E 6,9 methanoPGI2 or analogue thereof with safety, low cost, ease of treatment and high chemical yield, and further without producing side reactions, it has been discovered that a new intermediate of the formula III wherein X represents an acetoxy group and Y represents a tetrahydropyran 2yl group, is surprisingly advantageous. The present invention accordingly provides new bicycld 3.3.0 octane derivatives of the general formula EMI9.1 wherein Ac represents an acetyl group, THP represents a tetrahydropyran 2 yl group and R represents a formyl group or a group of the general formula EMI9.2 in which one of R and R represents a hydroxy group and the other represents a hydrogen atom, or R1 and R2 together represent an oxo group, R3 represents a single bond or a straight or branched chain alkylene group cf 1 to 5 carbon atoms and R represents a straight or branched chain alkyl group of l 1 to 8 carbon atoms, a straight or branched chain alkenyl or alkynyl group of 2 to 8 carbon atoms, a cycloalkyl group of 4 to 7 carbon atoms, either unsubstituted or substituted by at least one straightor branched chain alkyl group of 1 to 8 carbon atoms or represents a phenyl group or phenoxy group either unsubstituted or substituted by at least one halogen atom, trifluoromethyl group or straight or branched chain alkyl group of 1 to 4 carbon atoms, and the double bond in formula VIII is E with the proviso that when R3 represents a single bond, R4 does not represent a substituted or unsubstituted phenoxy group , which are useful as intermediates in the preparation of 6,9methano PGI2 and derivatives thereof. In the above structural formulae and in .the other structural formulae in this specification, according to the generally accepted nomenclature, the broken line indicates that the substituent attached thereto is behind the ring plane, i.e. is of the a configuration, the bold line r indicates that the substituent attached thereto is in front of the ring plane, i.e. is of the B configuration, and the wavy lxne indicates that the substituent attached thereto is of the a configuration or the 6 configuration or a mixture thereof. The present invention is concerned with all compounds of general formula VII in the optically active natural form or its enantiomeric form, or mixtures thereof, more particularly the racemic form, consisting of equimolecular mixtures of the optically active natural form and its enantiomeric form. As will be apparent to those skilled in the art, the compounds depicted in general formula VII have at least five centres of chirality, those five centres of chirality being at the C l, C 3, C 5, C 6 and C 7 carbon atoms. Still further centres of chirality may occur when one of R1 and R2 in the general formula VIII represents a hydroxy group and the other represents a hydrogen atom, and when the grouping R3 R4 in the general formula VIII contains a branched chain alkylene group or represents a branched chain alkyl group. The presence of chirality leads, as is well known, to the existence of isomerism.However, the compounds of general formula VII all have a configuration that the substituent groups attached to the ring carbon atoms in the positions identified as 1 and 5 are cis with respect to each other and that the substituent groups attached to the ring carbon atoms in the positions identified as 5 and 6 are t ns with resptS to each other.Accordingly, all isomers of general fcmnula VII and mixtures thereof which have those substituent groups attached to the ring carbon atoms in positions 1 and 5 in the cis configuration, those attached in positions 5 and 6 in the trans configuration and the acetyl group as depicted in the 3 position and the tetrahydropyran 2 yl group as depicted in the 7 position are to be considered within the scope of general formula VII. In the general formula VIII, as the alkylene group of 1 to 5 carbon atoms represented by R3 there may be mentioned methylene, ethylene, trimethylene, tetramethylene, and pentamethylene and isomers thereof. R3 preferably represents a single bond or a methylene or ethylene group. In the general formula VIII, as the alkylgmup of 1 to 8 carbon atoms or alkenyl or alkynyl group of 2 to 8 carbon atoms represented by R4 ,there may be mentioned methyl, ethyl, propyl, butyl, pentyl1 hexyl, heptyl,and octyl and isomers thereof and the corresponding unsaturated groups containing 2 to 8 carbon atoms, having a double bond or a triple bond then in, butyl, pentyl or hexyl groups optionally having a double bond or a triple bond therein and either unsiiiited or substituted by one or two methyl or ethyl groups are preferred. In the general formula VIII, as the substituted or unsubstituted cycloalkyl group represented by R4, there may be mentioned cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl groups substituted by one or more methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl or octylgrqps cyclobutyl, cyclopentyl or cyclohexyl groups either unsubstituted or substituted by one methyl, ethyl, propyl or butyl group are preferred. In the general formula VIII, as the substituted or unsubstituted phenyl or phenoxy group represented by R4, there may be mentioned phenyl and phenoxy groups, and phenyl and phenoxy groups substituted by one or more atoms or groups selected from fluorine and chlorine atoms, and trifluoromethyl, methyl, ethyl, propyl or butyl groups phenyl or phenoxy groups either unsubstituted or substituted by one chlorine atom, trifluoromethyl group, methyl group or ethyl group are preferred. In the general formula VIII,a6zeSS i groIngs R3 R4, there may be mentioned butyl, pentyl, l methylpentyl, 2 methylpentyl, 3 methylpentyl, l,l dimethylpentyl, l ethylpentyl, 2 ethylpentyl, hexyl, l methylhexyl, 2 methylhexyl, l ethylhexyl, 2 ethylhexyl, heptyl, 2 methylheptyl, 2 ethylheptyl, 4 methylpent 3 enyl, 2,4 dimethylpent 3 enyl, pent 3 ynyl and 1 methylpent 3 ynyl cyclobutyl, l propylcyclobutyl, 1 butylcyclobutyl, 3 ethylcyclobutyl, 3 propylcyclobutyl, cyclopentyl, cyclopentylmethyl, 2 cyclopentylethyl, 3 ethylcyclopentyl, 3 propylcyclopentyl, 3 butylcyclopentyl, cyclohexyl, cyclohexylmethyl, 2 cyclohexylethyl, 4 methylcyclohexyl, 4 ethylcyclohexyl, 4 propylcyclohexyl and 4 butylcyclohexyl and also benzyl, 2 phenylethyl, 4 methylbenzyl, 4 ethylbenzyl, phenoxymethyl, 2 phenoxyethyl, 3 chlorophenoxymethyl, 4 chlorophenoxymethyl, 3 trifluoromethylphenoxymethyl, 4 trifluoromethylphenoxymethyl, 4 methylphenoxymethyl and 4 ethylphenoxymethyl cyclopentyl is especially preferred. Further, in the general formula VIII, the preferred configuration of the hydroxy group is the a configuration, when one of R1 and R2 represents a hydroxy group and the other represents a hydrogen atom. Compounds of general formula VII wherein the grouping R R represents a cycloalkyl group of 4 to 7 carbon atoms either unsubstituted or substituted by at least one straight or branched chain alkyl group of 1 to 8 carbon atoms, especially a cyclopentyl group, are especially preferred.According to a feature of the present invention, compounds of the general formula VII wherein R represents the group of the general formula VIII. in which one of R1 and R2 represents a hydroxy group and the other represents a hydrogen atom, i.e. compounds of the general formula EMI14.1 wherein the various symbols are as hereinbefore defined may be prepared by reducing a compound of the general formula VII wherein R represents the group of the general formula VIII, in which R and R2 together represent an oxo group, i.e. a compound of the general formula EMI14.2 wherein the various symbols are as hereinbefore defined, The reduction to convert the oxo group to a hydroxy group may be carried out by using any suitable reducing reagent such as sodium borohydride, potassium borohydride, lithium borohydride, zinc borohydride, lithium tri tert butoxyaluminium hydride, lithium trimethoxyaluminium hydride. sodium cyanoborohydride, potassium tri sec butylborohydride, lithium aluminium hydride quinine complex, isobornyloxymagnesium iodide in an inert organic solvent a e.g. an alkanol containing from 1 to 4 carbon atoms such as methanol, ethanol or isopropanol, or an ether such as tetrahydrofuran.dioxan or 1,2 diethoxyethane. or a mixture of two or more such solvents. at a temperature from 78 C to ambient.Preferably, the reduction is effected using di iso bornyloxyaluminiumisopropoxide described in ourJapanese Patent Xokai No. 54 76552 , or a diisobutyl alkyl substituted or on unsubstituted phenoxyaluminium described in our JapanesePatent Kokai No. 54 154739 and J. Org. Chem., 44, 1363 1979 , or a lithium 1,1 binaphthyl 2.2 dioxyaluminium hydride described in J. Amer. Chem. Soc., 101, 5B3 l979 . The product thus obtained is a mixture of isomers in which the 3 hydroxy group is in a or ss configuration and the mixture, if desired, is separated by conventional means, for example, by thin layer, column or high speed liquid chromatography on silica gel to give the desired isomer of general formulaVIIA. According to a further feature of the invention compounds of the general formula VIIB may be prepared by subjecting to the Wittig reaction a compound of the general formula VII wherein R represents a formyl group, i.e.by reacting a compound of the general formula EMI16.1 wherein the various symbols are as hereinbefore defined with a sodium derivative of a dialkyl phosphonate of the general formula EMI16.2 wherein R5 represents an alkyl group of 1 to 4 carbon atoms. preferably methyl or ethyl. and the other symbols are as hereinbefore defined , or with a phosphorane compound of the general formula EMI16.3 wherein R6 represents a phenyl group unsubstituted or substituted by at least one alkyl group of 1 to 4 carbon atoms, preferably phenyl, or represents an alkyl group of 1 to 6 carbon atoms, preferably butyl or hexyl or represents a cyclohexyl group, and the other symbols are as hereinbefore defined . The sodium derivative of the dialkyl phosphonate of the general formula IX may be prepared by the reaction of the dialkyl phosphonate and sodium hydride. The Wittig reaction is described in OrganicReactions , Volume 14, Chapter 3 1965 , John Wiley Sons, Inc. USA . The reaction may be effected in an inert organic solvent, e.g. an ether such as diethyl ether, tetrahydrofuran, dioxan or 1,2 dimethoxyethane, a hydrocarbon such as benzene, toluene, xylene or hexane, a dialkyl sulphoxide such as dimethyl sulphoxide, a dialkylformamide such as N,N dimethylformamide, a halogenated hydrocarbon such as methylene chloride or chloroform, or an alkanol containing from 1 to 4 carbon atoms such as methanol. or ethanol. or a mixture of two or more of them, at a temperature from 780C to the reflux temperature of the reaction mixture. Dialkyl phosphonates of the general formula IX and phosphorane compounds of the general formula X are well known, or may easily be prepared by methods known per se. By the term methods known per se as used in this specification is meant methods heretofore used or described in the chemical literature. Bicyclo 3.3.0 octane derivatives of the general formula VIIC may be prepared by the series of reactions depicted schematically below in Scheme A, wherein 0 represents a phenyl group and the other symbols are as hereinbefore defined. The preparation of the derivatives of general formula VIIC from the compounds of general formula XVI constitutes a feature of the present invention. Scheme AEMI18.1 All of the individual reaction steps in SchemeA may be conducted by methods known per se, and suitable reaction conditions are described in the specification of the British Patent No. 2017699B Derwent No. 73954B .For example. step a 1 the protection of the hydroxy group by the tetrahydropyran 2 yl group, may be conducted by using 2,3dihydropyran in an inert organic solvent such as methylene chloride in the presence of a condensing agent, e.g.p toluenesulphonic acid or sulphuric acid at a temperature from ambient to 300C, preferably at ambient. The step bi . reduction, may be conducted by means heretofore mentioned for the conversion of compounds of general formula VIIB to those of general formula VI IA suitably it is effected by using sodium borohydride in methanol at a temperature lower than OOC. The product of the general formula XIII thus obtained is a mixture of isomers in which the 3 hydroxy group is in a or ss configuration. However the separation of such mixture is unnecessary because the 3 hydroxy group is converted again into an oxo group in a subsequent reaction step. The step cl, acetylation, may be conducted by using acetic anhydride in the presence of a tertiary amine such as pyridine or triethylamine in an inert organic solvent such as methylene chloride, or in the absence of the solvent at room temperature. The step d , debromination , may be conducted by gentle refluxing using tributyltin hydride in the presence of ,a azo bisisobutyronitrile in an inert organic solvent such as benzene, toluene or ethyl acetate.The step e , cleavage of the benzyl group, may be generally conducted by hydrogenolysis in the presence of a hydrogenation catalyst such as palladium on carbon, palladium black or platinum dioxide, in an inert organic solvent, for example a lower alkanol such as methanol or ethanol at room temperature at normal or elevated pressure, for example at a hydrogen pressure from atmospheric to 15 kg cm2. Suitably the cleavage may also be conducted by using Raney Nickel catalyst in a lower alkanol such as methanol or ethanol under an atmosphere of an inert gas, for example under an atmosphere of argon gas at a temperature from ambient to the reflux temperature of the reaction mixture. For the purpose of commercial mass production it is of great significance that Raney Nickel can be used as catalyst from a view point of safety.The step. f . oxidation, may be carried out as described in detail in, for example. a Synthetic Organic Chemistry 1111 OrganicSynthesis 1 , pp. 176 206 compiled by Tetsuji Kametani and published by Nankodo Japan on Aug. 1, 1976 or b Compendium of Organic Synthetic Methods , vol. 1, vol. 2. and vol. 3, section 48 or 168 published by John Wiley Sons, Inc. USA in 1971, 1974 and 1977, respectively . me oxidation is preferably carried out under mild neutral conditions using, for example, sulphuric anhydridepyridine complex see J. Amer. Chem. Soc., 89, 5505 1967 , chromium trioxide pyridine complex for example, Collins reagent , Jones reagent or chromic acid solution prqxred from chromium trioxide, manganese sulphate, sulphuric acid and water , or oxalyl chloride and dimethylsulphoxide i.e. Swern oxidation . The oxidation using sulphuric anhydride pyridine complex may be carried out in dimethyl sulphoxide in the presence of triethylamine at room temperature. The Collins oxidation may be conducted in a halogenated hydrocarbon such as chloroform, methylene chloride or carbon tetrachloride at a temperature from room temperature to O C, preferably at O C.The Jones oxidation may be conducted at a temperature of not higher than room temperature. The Swern oxidation may be conducted by reaction in a halogenated hydrocarbon such as chloroform or methylene chloride at a temperature from 50 C to 60 C, and then treatment with triethylamine. In the oxidation of the compound of formula XVI a side reaction to form a double bond between the C6 andC7 positions which may occur as hereinbefore described in the compound of formula V does not occur because the hydroxy group at the 7 position is protected not by a benzoyl group but by a tetrahydropyran 2 yl group. In the sequence of the reaction steps illustratd by the above scheme A, the compound of the formula XI employed as the starting material is known per se, and is described in the specification of the British PatentNo. 201699B Derwent No. 73954B . The bicyclo 3.3.O octane compou ld.s of the general formula VIIA of the present invention may be converted to pharmacologically active 6,9 methano PGI2 analogues of the general formula EMI22.1 wherein the various symbols are as hereinbefore defined by the series of reactions depicted schematically below in Scheme B, wherein BMS represents a tert butyldimethyl silyl group and the other symbols are as hereinbefore defined. Scheme BEMI23.1 Scheme B continued EMI24.1 All of the individual reaction steps in SchemeB may be conducted by methods known per se, and suitable reaction conditions are described in the specification of the British Patent No. 2017699B Derwent No. 73954B .For example, step g , the protection of the hydroxy group by the tert butyldimethylsilyl group, may be conducted by using tert butyldimethylsilyl chloride in an inert organic solvent such as dimethylformamide in the presence of a base such as imidazole at room temperature The step h . deacetylation, may be conducted by using potassium carbonate in methanol at room temperature. The step i may be conducted as described for step f . The step j , the Wittig reaction, may be conducted by reaction with 4 carboxybutylidene triphenylphosphorane of the formula 3P CH CH2 3 COOH in which is as hereinbefore defined in toluene at room temperature. The phosphorane compound may be obtained by the reaction of 4 carboxybutyl triphenylphosphonium bromide with potassium tert butoxide.The step k , esterification, may be conducted by using a solution of diazomethane in diethyl ether, in ethyl acetate at room temperature. The e step 1 , cleavage of the tert butyl dimethylsilyl group, may be conducted by using tetrabutylammonium fluoride n Bu4N F in tetrahydrofuran at room temperature. The step m , oxidation, may be conducted as described for the step f . The step n , cleavage of the tetrahydropyran 2 yl group, may be conducted by using a mixture cf tetrahydrofuran, acetic acid and water. a mixture of p toluenesulphonic acid and methanol, or a mixture of dilute hydrochloric acid and tetrahydrofuran at room temperature or under beating. The step o , separation of 5E isomer from 5Z isomer, may be conducted by conventional means, for example, by thin layer, column or high speed liquid chromatography on silica gel, The step p may be conducted by means heretofore mentioned for the conversion of compounds of general formula VIIB to those of general formula VIIA. The step q , saponification, may be conducted by using an aqueous solution of potassium hydroxide in ethanol. Compounds of the general formulXXVI and I may, if desired, be purified by recrystallization from a suitable solvent. In the sequence of the reaction steps described above, the separation of 5E isomer from 5Z isomer may also be carried out after introduction of the a chain by the Wittig reaction i.e. purification of the compound of the general formula XX , or as final product i.e.purification of the compound of the general formula I in good yield. The separation of 5E isomer in the form of the compound of the general formula XXIV having an enone groupEMI26.1 gives the highest yield. The proportion of 5E isomer to 5Z isomer is about 5 to i when the separation is conducted in the step o . As described above, the separation of SE isomer from 5Z isomer may also be conducted on the compound of the general formula XX or on the compound of the general formula I . In such case, itis not necessary to use different protecting groups at the 11 and 15positions, the sequence of the reaction steps then being different from that shown in Scheme B. It is then possible to decrease the number of reaction steps from the compound of the general formula VIIA to the final product. Furthermore, the separation of 5E isomer may be carried out in the form of a dicyclohexylamine salt of the final product see Japanese Patent Kokai No.56 122328 as well as by conventional chromatographic separations. When the separation is carried out after introduction of the a chain by the Wittig reaction or on the final product. compounds of the general formulaI may be prepared from a compound of the general formulaVIIA by the series of reactions depicted schematically below in Scheme C, wherein the various symbols are as hereinbefore defined. Scheme CEMI28.1 Scheme C continued EMI29.1 All of the individual reaction steps in SchemeC may be conducted by methods known peruse, and suitable conditions are described in the specification of BritishPatent No. 2017699B Derwent No. 73954B . For example, step r , protection by a THP group, may be conducted as hereinbefore described for the step a . The step s , deacetylation,may be conducted as hereinbefore described for the step h . The step t , oxidation, may be conducted as hereinbefore described for the step f . The step u3, the Wittig reaction, may be conducted as hereinbefore described for the step j .The steps v, y3 and aa , cleavage of the THP group, may be conductea as hereinbefore described for the step n . The steps and and x . separation of 5E isomer and 5Z isomer, may be conducted as hereinbefore described for the step to . Recrystallization can, if desired, give 5E isomer in higher purity.The step x may be also carried out by forming a dicyclohexylamine salt, i.e., it can be conducted by forming a dicyclohexylamine salt of a compound of the general formula XXXI by using dicyclo hexylamie in a suitable solvent, e.g. acetone, and then, if desired, recrystallizing the resulting salt from a suitable solvent, and thereafter converting the salt to the free carboxylic acid under acidic aqueous conditions, e.g. in an aqueous solution of potassium bisulfate, to give a compound of the general formula I rich in 5E isomer thereof. The step z , esterification, may be conducted as hereinbefore described for the step k , or by using methyl iodide in acetone in the presence of an alkali metal, e.g. potassium, carbonate.The step bb , saponification, may be conducted as hereinbefore described for the step q . Compounds of the general formulae XXXIV and I may, if desired, be purified by recrystallization from a suitable solvent. The 5E 6,9 methano PGI2 and derivatives thereof thus obtained have various useful pharmacological properties, see British Patent No. 2017699B, and BritishPatent Publication Nos. 2012265A, 2013661A, 2014143A and 2019847A, and the German Patent Application No. P3315356.6 . It will be appreciated, therefore, that the new compounds of the present invention.of the general formulaVII, i.e. compounds of the general formula VIIA, VIIB andVIIC are useful and important intermediates for the preparation of therapeutically useful 5E 6,9 methanoPGI2 and derivatives thereof. The use of the bicyclo 3.3.0 octane compounds of the general formula VII allows the synthesis of 5E 6,9 methano PGI2 and derivatives thereof by the methods hereinbefore described which avoid certain disadvantages in the use of compounds of the general formula IV and VI and other bicyclo 3.3.0 octane compounds. The use of the compounds of the general formula VII avoids the production of by product, and the need to use a ketal group as a protecting group of a ketone, and enables debenzylation to be carried out using RaneyNickel catalyst. The following Reference Examples and Examples illustrate the preparation of compounds of the present invention. In the Reference Examples and Examples, TLC , NMR , IR and Mass represent Thin layer chromatoyE Ã½ , Nuclear magnetic resonance spectrum , Infrared absorption spectrum and Mass spectrum , respectively.The solvents in parentheses specified in chromatographic separations show the developing solvents used ratios are by volume. Except when specified otherwise, infrared absorption spectra were recorded by the liquid film method and nuclear magnetic resonance spectra were recorded in deuterochloroform CDc13 solution. Reference Example 1 6 syn benzyloxymethyl 7 anti tetrahydropyran 2 ylOxy 8 syn bromo cis bicyclo 3.3.0 octan 3 one Under an atmosphere of argon, to a mixture of 4.7 g of 6 syn benzyloxymethyl 7 anti hydroxy 8 syn bromo cis bicyclo 3.3.0 octan 3 one prepared as described in the specification of the British PatentNo. 2017699B Derwent No. 73954B , Reference Example 4 1.52 g of 2,3 dihydropyran and 50 ml of methylene chloride was added a catalytic amount of p toluene sulphonic acid, and the mixture was stirred for 20 minutes at room temperature. To the reaction mixture was added a saturated aqueous solution of sodium bicarbonate and the mixture was extracted with ethyl acetate. The extract was washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give ca. 6.0 g of the title compound as crude product having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.47 NMR 6 7.34 5H, s , 5.00 4.65 1H, m , 4.55 2H, s , 4.50 3.20 6H, m IR w 3040, 2950, 2860, 1742, 1451, 1404, 1356, 1200, 1121, 1078, 1035, 968, 740, 700 cm 1 Mass m e 422 M r 337, 241, 191, 151, 135, 107, 101, 91, 85.Reference Example 2 6 syn benzyloxymethyl 7 anti tetrahydropyran 2 yloxy 8 syn bromo cis bicyclo 3. 3.0 octan 3aB ol To a mixture of ca 6.0 g of the bicycloI3.3.01 octan 3 one compound prepared in Reference Example 1 and 65 ml of methanol were added 950 mg of sodium borohydride little by little over a period of 10 minutes at 200C. After stirring 5 minutes, acetic acid was added thereto to decompose an excess amount of sodium borohydride and the reaction mixture was concentrated under reduced pressure to remove methanol.To the residue obtained was added water and the mixture was extracted with ethyl acetate and the extract was washed with a saturated aqueous solution of sodium bicarbonate, water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give ca. 6.2 g of the title compound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.31 and 0.36. Reference Example 3 3aB acetoxy 6 syn benzyloxymethyl 7 anti tetrahydro pyran 2 yloxy 8 syn brorno cis bicyclo 3.3.0 octane A mixture of ca. 6.2 g of the bicyclo 3.3.0 octan 3 ol compound prepared in Reference Example 2 , 5.2 ml of acetic anhydride and 8.8 ml of pyridine was stirred for 5 hours at room temperature and concentrated under reduced pressure.The residue thus obtained was diluted with ethyl acetate, washed with 1N hydrochloric acid, a saturated aqueous solution of sodium bicarbonate, water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give ca. 6.45 g of the title compound as crude product having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.50 NMR 6 7.32 5H, s , 5.22 1H, m , 4.94 and 4.73 lH, m , 4.51 2H, s , 4.20 3.36 6H, m , 2.02 3H, s IR v 1735, 1450, 1370, 1240, 1130, 1070, 1025, 970, l 905, 870, 815, 735, 695 cm Mass m e 466 M , 381, 215, 191, 179, 165, 151, 135, 119, 105, 101, 91, 85. Reference Example 4 3aB acetoxy 6 syn benzyloxymethyl 7 anti tetrahydro pyran 2 yloxy cis bicyclo 3.3.0 octane Under an atmosphere of argon, a mixture of ca.6.45 g of the B bromo bicyclo 3.3.0 octane compound prepared in Reference Example 3 , 4.25 g of tributyltin hydride, 67 mg of a,a azobisisobutyronitrile and 60 ml of benzene was refluxed gently for 1.2 hours. The reaction mixture was concentrated under reduced pressure and the residue was purified twice by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 5.07 g of the title compound having the following physical characteristics TLC benzene ethyl acetate 4 Rf 0.50 NMR d 7.31 513, s , 5.30 5.05 1H, m , 4.70 4.43 3H, m , 4.06 3.38 5H, m , 2.02 3H, s IR v 1735, 1450, 1370, 1355,1250, 1120, 1075, 1025, 975, 910, 865, 810, 735, 695 cm Mass m e 388 M , 303, 286, 243, 227, 209, 195, 180, 151, 137, 120, 101, 91, 85, 79, 67.Reference Example 5 3aB acetoxy 6 syn hydroxymethyl 7 anti ttetrahydro pyran 2 yloxy cis bicyclo 3.3.0 octane To a solution of 6.25 g of sodium hydroxide in 25 ml of water were added slowly 5 g of a 50 aluminiumnickel alloy over a period of 20 minutes at 500C and the mixture was stirred for 45 minutes at the same temperature. The supernatant solution was decanted and the residue was washed with water and ethanol, successively to give Raney Nickel. To Raney Nickel thus obtained were added 20 ml of ethanol and a solution of 1.94 g of the 6 benzyloxy methyl bicyclol3.3.0Zoctane compound prepared inReference Example 4 in 20 ml of ethanol was added thereto all at once with gentle refluxing and the mixture was refluxed for 1.5 hours under an atmosphere of argon. The reaction mixture was filtered through celite and concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 1.35 g of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Ref 0. 1 NMR 6 5.15 1H, m , 4.68 and 4.57 1H, m , 4.00 3.44 5H, m , 2.03 3H, s IR v 3460, 1735, 1435, 1375, 1250, 1135, 1075, 1020, l 980, 910, 870, 810 cm Mass m e 288 M , 280, 238, 225, 213, 196, 179, 155, 137, 119, 101, 85, 67.Example 1 3a B acetoxy 6 syn formyl 7 anti tetrahydropyran 2 yloxy cis bicyclol3.3.01octane Under an atmosphere of argon, to a mixture of 1.32 g of the 6 hydroxymethyl bicyclo 3.3.0 octane compound prepared in Reference Example 5 , 3.61 ml of triethylamine and 10 ml of dimethyl sulphoxide was added dropwise a solution of 2.07 g of sulphuric anhydridepyridine complex in 4 ml of dimethyl sulphoxide at room temperature and the mixture was stirred for 10 minutes at the same temperature. The reaction mixture was poured into 70 ml of ice water and extracted with a mixture of ethyl acetate and diethyl ether 1 1 . The extract was washed with 1N hydrochloric acid, a saturated aqueous solution of sodium bicarbonate and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give 1.31 g of the title compound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane l 2 Rf 0.30. Example 2 E 3aB acetoxy 6 syn 3 oxo 3 cyclopentylprop l enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3.3.0 octane Under an atmosphere of argon, to a suspension of 216 mg of sodium hydride content 64.18 in 25 ml of tetrahydropyran was added dropwise a solution of 1.46 g of dimethyl 2 cyclopentyl 2 oxoethylphosphonateEMI39.1 in 7 ml of tetrahydrofuran at room temperature and the mixture was stirred for 30 minutes at the same temperature. To the solution thus obtained was added dropwise a solution of 1.31 g of the 6 formyl bicyclo 3.3.0 octane compound prepared in Example 1 in 7 ml of tetrahydrofuran and the mixture was stirred for 20 minutes at room temperature.The reaction fixture was poured into a saturated aqueous solution ot ammonium chloride and extracted with ethl acetate. The extract was washed with water and saturated aqueous solution of sodium chloride, successively, cried over anhydrous magnesium sulphate and concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 1.5 g of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.40 NMR 6 6.91 6.70 1H, m , 6.28 6.14 1H, m , 5.15 1H, m , 4.68 and 4.54 1H, m , 4.03 3.68 2H, m , 3.46 1H, m , 3.08 1H, m , 2.04 3H, s IR v 1735, 1690, 1660, 1620, 1430, 1360, 1230, 1120, 1065, 1010, 965 cm 1 Mass m e 305, 288, 246, 229, 218, 205, 202, 177, 149, 97, 85, 69, 67.Example 3 E 3aB acetoxy 6 syn 3c B hydroxy 3 cyclopentylprop l enyl 7 anti tetrahydropyran 2 yloxy cis bicyclol3.3.0 octane Proceeding as described in Reference Example 2, from 375 mg of the 6 3 oxo 3 cyclopentylprop lenyl bicyclo 3.3.0 octane compound prepared in Example 2 , there were obtained 380 mg of the title compound as crude product, having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.20 and 0.22 NMR 6 5.58 2H, m , 5.12 1H, m , 4.65 1H, m , 3.94 3.65 3H, m , 3.46 1H, m , 2.03 3H, s IR v 3460, 1735, 1440, 1375, 1245, 1120, 1075, 1020, 975 cm Mass m e 290, 272, 248, 230, 221, 212, 196, 186, 161, 149, 136, 85, 69, 67.Reference Example 6 E 3aB acetoxy 6 syn 3aB tert butyldimethylsilyloxy 3 cyclopentylprop l enyl 7 anti tetrahydropyran 2 yldxy cis bicycld 3.3.0 octane Under an atmosphere of argon, a mixture of 350 mg of the 6 3aB hydroxy 3 cyclopentylprop l enyl bicyclo 3.3.030ctane compound prepared in Example 3 , 202 mg of tert butyldimethylsilyl chloride, 109 mg of imidazole and 4 ml of dimethylformamide was stirred for one hour at room temperature and the reaction mixture was poured into 25 ml of ice water.The mixture was extracted with diethyl ether and the extract was washed with 1N hydrochloric acid, a saturated aqueous solution of sodium bicarbonate, water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give ca. 460 mg of the title compound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.61. Reference Example 7 E 6 syn 3aS tert butyldimethylsilyloxy 3 cyclo pentylprop l enyl 7 anti tetrahydropyran 2 ylOxy cis bicyclo 3.3.0 octan 3aB ol Under an atmosphere of argon, a mixture of ca.460 mg of the 3 acetoxy bicyclo 3.3.0 octane compound prepared in Reference Example 6 , 122 mg of potassium carbonate and 5 ml of methanol was stirred for 15 minutes at room temperature, and further for 30 minutes at 350C. The reaction mixture was poured into a cooled saturated aqueous solution of ammonium chloride and extracted with ethyl acetate. The extract was washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 367 mg of the title compound having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.39 and 0.43. Reference Example 8 E 6 syn 3aB tert butyldimethylsilyloxy 3 cyclo pentylprop l enyl 7 anti tetrahydropyran 2 ylOxy cis bieyclo 3.3.0 octan 3 one Proceeding as described in Example 1, from 350 mg of the bicyclo 3.3.01octan 3 ol compound prepared inReference Example 7 , there were obtained 300 mg of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Ref 0.58 NMR 6 5.50 2H, m , 4.70 1H, m , 4.18 3.80 3H, m , 3.50 lH, m , 0.91 9H, s , 0.05 6H, m IR w 1735, 1450, 1405, 1360, 1255, 1120, 1080, 1035, 975, 915, 865, 835, 780 cm 1, Mass m e 405, 393, 361, 321, 313, 309, 293, 291, 215, 201, 177, 171, 159, 85, 65, 63.Reference Example 9 SEZ,13E 9a,lla,lSaB 6,9 methano ll tetrahydropyran 2 ylOxy 15 tert butyldimethylsilyloxy 15 cyclopentyl 16,17,18,19 ,20 pentanorprosta 5,13 dienoic acid Under an atmosphere of argon, a mixture of 532 mg of 4 carboxybutyl triphenylphosphonium bromide, 260 mg of potassium tert butoxide and 4 ml of toluene was stirred for 40 minutes at 80or. After cooling to room temperature, thereto was added a solution of 185 mg of the bicyclo 3.3.0 octan 3 one compound prepared inReference Example 8 in one ml of toluene at room temperature and the mixture was stirred for 1.5 hours at the same temperature. To the reaction mixture were added 4 ml of cooled water and the mixture was adjusted to pH 4 with 1N hydrochloric acid and extracted with diethyl ether. The extract was washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 166 mg of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.35 and 0.41 NMR 6 5.50 2H, m , 5.24 1H, m , 4.70 1H, m , 4.00 3.70 3H, m , 3.50 1H, m , 0.92 9H, s , 0.06 6H, m IR v 1710, 1450, 1250, 1115, 1075, 1030, 1015, 975, 830, 770 cm 1 Mass m e 489, 477, 471, 459, 444, 414, 405, 39 7, 393, 387, 375, 330, 313, 261, 159, 85, 75, 73. Reference Example 10 5EZ,13E 9a,11a,15aB 6,9 methano 11 tetrahydropyran 2 ylOxy 15 hydroxy 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid methyl ester To a solution of 154 mg of the prosta 5,13dienoic acid compound prepared in Reference Example 9 in 3 ml of ethyl acetate was added a dimethyl ether solution of diazomethane under cooling with ice until fe mixture turned to pale yellow,and then the mixture was concentrated under reduced pressure to give 5EZ,13E 9a,11 ,15aB 6,9 methano 11 tetrahydropyran 2 ylOxy 15 tert butyldimethylsilyloxy 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dieno acid methyl ester as crude product having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.66. The ester thus obtained was dissolved in 3 ml of dry tetrahydrofuran and 368 mg of tetrabutylammonium fluoride were added thereto and the solution was stirred for 5 hours at room temperature. Water and ethyl acetate was added to the reaction mixture and its aqueous layer was adjusted to pH 4 with 1N hydrochloric acid and extracted with ethyl acetate. The extract was washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give i03 mg of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.33 and 0.36 NMR 6 5.63 5.50 2H, m , 5.21 1M, m , 4.65 1H, m , 3.94 3.68 3H, m , 3.66 3H, s , 3.45 1H, m IR v 3470, 1735, 1435, 1245, 1200, 1160, 1120, 1075, 1010, 975, 915, 865, 810 cm 1 Mass m e 428, 384, 344, 326, 300, 178, 131, 119, 117, 105, 91, 85, 69, 67.Reference Example 11 5EZ,13E 9a 6,9 metharob tetr hy ropyrar. 2 ylOxy 15 oxo 15 cyclopentyl 16,17,1 , 9,20 pentanor prosta 5,13 dienoic acid methyl ester Proceeding as described in Example 1, from 90 mg of the 15 hydroxyprosta 5,13 dienoic acid methyl ester compound prepared in Reference Example 10 , there were obtained 79 mg of the title ccmpound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane l 2 Ri 0.49. Reference Example 12 5EZ,13E 9a 6,9 methano 11 hydroxy 15 oxo 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid methyl ester A mixture of, 79 mg of the ll tetrahydropyran 2 yloxy prosta 5,13 dienoic acid methyl ester compound prepared in Reference Example 11 , 2 ml of a 65 v v aqueous solution of acetic acid and 0.3 ml of tetrahydrofuran was stirred for 1.5 hours at 500C and thereto was added ice water and the mixture was extracted with ethyl acetate. The extract was washed with a saturated aqueous solution of sodium bicarbonate and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of methylene chloride and diethyl ether to give 57 mg of the title compound having the following physical characteristics TLC ethyl acetate cyclohexane 1 2, twice developed Rf 0.30 and 0.34 NMR 6 6.72 lH, dd , 6.10 lH, d , 5.5 4.92 1H, m , 3.6 3H, s IR v 3450, 2960, 2875, 1740, 1690, 1660, 1620, 1450, 1435 cml Mass m e 360 M , 342, 316, 311, 273, 245, 179, 162, 149, 147, 131, 129,119, 107, 105, 97, 91, 79, 69.Reference Example 13 5E,13E 9 alpha ,11 alpha 6,9 methano 11 hydroxy 15 oxo 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid methyl ester and the corresponding 5Z isomer 2.3 g of the 5EZ mixture prepared inReference Example 12 were purified by chromatography on a Loba column. Art 10401 Lobar is a registered Trade Mark of Merck Co., Inc. eluent a mixture of cyclohexane and ethyl acetate 4 1 3 1 to give 1.51 g of the title compound SE isomer , 310 mg of the corresponding 5Z isomer and 307 mg of the mixture thereof, having the following physical characteristics a the title compound 5E isomer TLC ethyl acetate cyclohexane 1 2, twice developed Rf 0.30 NMR 6 6.72 1H, dd , 6.10 1H, d , 5.5 4.92 1H, m , 3.6 3H, s IR v 3450, 2960, 2875, 1740, 1690, 1660, 1620, 1450., 1435 cmMass m e 360 M , 342, 316, 311, 273, 245, 179, 162, 149, 147, 131, 129, 119, 107, 105, 97, 91, 79, 69. b the corresponding 5Z isomer TLC ethyl acetate cyclohexane 1 2, twice developed Rf 0.34.Reference Example 14 5E,13E 9 ,11a,15a 6,9 methano 11,15 dihydroxy 15 cyclopentyl 16, 17,18,19, 20 pentanorprosta 5 , 13 dienoic acid methyl ester and the corresponding 15B hydroxy isomer Under an atmosphere of argon, to a solution of 17.2 g of 2,6 di tert butyl p cresol in 90 ml of toluene were added dropwise 23.6 ml of a 1.76 M solution of diisobutylaluminium hydride in toluene under cooling with ice and the mixture was stirred for 30 minutes at room temperature and then cooled to 780C. To the solution thus obtained was added dropwise slowly a solution of 1.51 g of the 15 oxo compound prepared inReference Example 13 all in 10 ml of toluene at 780C. After completion of adding dropwise, a cooling bath was removed and the temperature of the reaction mixture was raised to 20 C over a period of ca. 30 minutes with stirring the mixture and further to 130C over a period of ca. 40 minutes. The reaction mixture was quenched by adding 16 ml of water and stirred for 30 minutes at room temperature. The precipitate was filtered off and the filtrate was concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of methylene chloride and ethyl acetate, and ethyl acetate, successively to give 1.14 g of the title compound 15a hydroxy compound and 203 mg of the corresponding l5ss hydroxy isomer, both being as white crystal, having the following physical characteristics a the title compound 15a hydroxy isomer Melting point .77 790C recrystallized from a mixture of ethyl acetate and n hexane TLC ethyl acetate cyclohexane 2 1 Rf 0.26 NMR 6 5.87 4.83 3H, m , 4.27 3.4 2H, m , 3.6 3H, s IR KBr tablet method w 3380, 2950, 2875, 1740, 1450, 1430, 1315, 1250, 1195, 1170, 1130, 1085, 1020, 970 cm Mass m e 344, 326, 313, 300, 275, 232, 179. b the corresponding 15B hydroxy isomer TLC ethyl acetate cyclohexane 2 l .Rf 0.38. Reference Example 15 5E,13E 9a, lla,15a 6,9 methano 11,15 dihydroxy 15 cyciopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid i.e. 5E 15 cyclopentyl 16,17,18,19,20 pentanor 6,9 methano PGI2 A mixture of 1.08 g of the methyl ester compound prepared in Reference Example 14 all 15 ml of a 5 aqueous solution of potassium hydroxide and 15 ml of ethanol was stirred for 20 minutes at 450C andwesthen adjusted to pH 3 to 4 with 1N hydrochloric acid under cooling with ice. The reaction mixture was diluted with ethyl acetate, washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give 1.01 g of the title compound as crude crystal.The crude crystal thus obtained was recrystallized from a mixture of ethyl acetate and cyclohexane 1 2 to give 955 mg of the title compound as white powder having the following physical characteristics Melting point 102 1030C TLC ethyl acetate cyclohexane 3 1 containing 2 acetic acid Rf 0.23 NMR 6 6.55 4.95 6H, m , 4.2 3.35 2H, m IR KBr tablet method v 3350, 2950, 2875, 2650, 1710, 1450, 1430, 1410, 1375, 1250, 1220, 1130, 1080, 1020, 970 cm l Mass m e 330, 312, 286, 261, 243, 217, 165, 91, 69, 41. Example 4 E 3aB acetoxy 6 syn 3a hydroxy 3 cyclopentylprop l enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3.3.0 octane and the corresponding 3B hydroxy isomer Under an atmosphere of argon, to a suspension of 1.125 g of lithium aluminium hydride in 55 ml of tetrahydrofuran was added dropwise a solution of 1.48 ml of ethanol diluted in 15 ml of tetrahydrofuran over a period of 5 minutes at 100C, and further thereto was added dropwise a solution of 7.264 g of S 2,2 dihydroxy l l binaphthyl in 27 ml of tetrahydrofuran over a period of 10 minutes at 10 C and the mixture was stirred for 20 minutes at room temperature to give a suspension of lithium S l,l binaphthyl 2,2 dioxyethoxyaluminium hydride in tetrahydrofuran it is a reagent for selective reduction .Aftercoo3ing tbereagent thus obtained to 780C, thereto was added dropwise a solution of 1.65 g of the 6 3 oxo 3 cyclopentylprop l enyl bicyclo 3.3.0 octane compound prepared inExample 2 in 15 ml of tetrahydrofuran over a period of 10 minutes and the mixture was stirred for one hour at the same temperature.Methanol was added dropwise to the reaction mixture to decompose an excess amount of the reagent and then the temperature of the mixture was raised to 0 C. The reaction mixture was adjusted to pH 7 to 8 with 1N hydrochloric acid and filtered. The filtrate was washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of methylene chloride and ethyl acetate, and a mixture of ethyl acetate and cyclohexane, successively to give 1.53 g of the title compound 3ahydroxy isomer and 38 mg of the corresponding 3B hydroxy isomer having the following physical characteristics a the title compound 3a hydroxy isomer TLC ethyl acetate cyclohexane 1 2 Rf 0.20 NMR 6 5.58 2H, m , 5.12 1H, m , 4.65 1H, m , 3.94 3.65 3H, m , 3.46 1H, m , 2.03 3H, s IR v 3460, 1735, 1440, 1375, 1245, 1120, 1075, 1020, 975 cm 1 Mass m e 290, 272, 248, 230, 21, 212, 196, 186, 161, 149, 136, 85, 69, 67. b the corresponding 3B hydrcxy iTLC ethyl acetate cyclohexane 1 2 Rf 0.22 Reference Example 16 E 3as acetoxy 6 syn 3a tetrahydropytar ylOxy 3 cyclopentylprop 1 enyl 7 anti tetrahidropyran 2 yloxy cis bicyclo 3.3.03octane Proceeding as described in Reference Example 1, from 1.57 g of the 6 3a hydroxy 3 cyclopentylprop l enyl bicyclot3.3.0loctane compound prepared inExample 4 a , there were obtained 2.0 g of the title compound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.48.Reference Example 17 E 6 syn 3a tetrahydropyran 2 yloxy 3 cyclopentyl prop l enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3.3.0 octan 3 alpha ss ol Proceeding as described in Reference Example 7, from 2.0 g of the 3 acetoxy bicyclo 3,3,0 octane compound prepared in Reference Example 16 , there were obtained 1.8 g of the title compound as crude product having the following physical characteristic TLC ethyl acetate cyclohexane 1 2 Rf 0.19 and 0.23.Reference Example 18 E 6 syn 3a etrahydropyran 2 yloxy 3 cyclopent prop 1 enyl 7 anti tetrahydropyran 2 yloxy cis bicyclo 3.3.03Octan 3 one Proceeding as described in Example 1, from 1.8 g of the bicyclo 3.3.0 octan 3 ol compound prepared inReference Example 17 , there were obtained 1.5 g of the title compound having the following physical characteristics TLC ethyl acetate cyclohexanezl 2 Rf 0.34 NMR 6 5.7 5.2 2H, m , 4.65 2H, m , 4.2 3.1 6H, m IR v 1740, 980 cm 1 Mass m e 363, 331, 330, 279, 246, 228, 202, 177, run65, 152, 101, 94, 85, 67. 57. Reference Example 19 5EZ,13E 9a,11a,15a 6,9 methano 11,15 bis tetrahydro pyran 2 yloxy 15 cyclopentyl 16,17,18,19,20 pentanor prosta 5,13 dienoic acid Proceeding as described in Reference Example 9, from 1.47 g of the bicyclo 3.3.0 octan 3 one compound prepared in Reference Example 18 , there were obtained 1.554 g of the title compound 777 mg of the almost pure 5E isomer, 525 mg rich in SE isomer and 252 mg rich in 5Z isomer having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.24 and 0.30 NMR 6 5.70 5.13 3H, m , 4.65 2H, m , 3.96 3.33 6H, IR 9 1730, 1710, 1445, 1335, 1200, 1120, 1075, 1015, 975, 910, 865, 810, 755 cml Mass m e 414, 396, 370, 363, 330, 312, 286, 279, 261, 218, 164, 149, 105, 91, 85, 67, 57, 55.Reference Example 20 5EZ,13Ei 9 a,lla, 15a 6,9 methano 11,15 dihydroxy 15 cyclopentyl 16,17,18,19,20 per.tanorprosta 5,13 dienoic acid A mixture of 525 mg of the 11,15 bis tetrahydropyran 2 yloxy prosta 5,13 dienoic acid compound rich in SE isomer prepared in Reference Example 19 , 5 ml of 1N hydrochloric acid and 10 ml of tetrahydrofuran was stirred for 7 hours at room temperature, and further forl6 hours at O C. The reaction mixture was diluted with ethyl acetate and washed with water and a saturated aqueous solution of sodium chloride, successively, dried over anhydrous magnesium sulphate a 3 concentrated under reduced pressure.The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane to give 244 rr.g of the title compound as white crystal having the following physical characteristics TLC ethyl acetate cyclohene 3 i ccr.taining 2 acetic acid , twice developed Rf 0.44 and 0.49 NMR 6 6.55 4.95 6H, m , 4.2 3.35 2H, m IR KBr tablet method v 3350, 2950, 2875, 2650, 1710, 1450, 1430, 1410, 1375, 1250, 1220, 1130, 1080, 1020, 970 cm 1 Mass m e 330, 312, 286, 261, 243, 217, 165, 91, 69, 41.Reference Example 21 5E,13E 9a ,15 6,9 methano 11,15 dihydroxy 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid i.e. SE l5 cyclopentyl 16,17,18,19,20 pentanor 6, 9 methano PGI2 To a solution of 244 mg of the 5EZ mixture prepared in Reference Example 20 in 7.5 ml of acetone was added 0.14 ml of dicylohexylamine and after adequate dissolution, the solution was allowed to stand for 18 hours at room temperature, and the precipitated crystals were filtered and washed with acetone. The crystals obtained were dissolved in a 0.SN aqueous solution of potassium bisulphate and extracted with ethyl acetate.The extract was washed with water and a saturated aqueous solution of sodium chloride, successively and concentrated under reduced pressure to give, 145 mg of the white crystals. The crystals thus obtained were recrystallized from a mixture of ethyl acetate and cyclohexane 1 2 to give 114 mg of the title compound as white crystal having the same physical characteristics provided that the Rf value of TLC shows 0.44 as those of the product prepared in ReferenceExample 20.Reference Example 22 SE,13E 9a,lla,15a 6,9 methano l1,15 dihydroxy l5 cyclopentyl 16,17,18,19,20 pentanorprosta S,13 dienoic acid i.e. SE 15 cyclopentyl 16,17,18,19,20 pentanor 6,9 methano PGI2 Proceeding as described in Reference Example 20, from 757 mg of the ll,l5 bis tetrahydropyran 2 yloxy prosta 5,13 dienoic acid compound almost pure SE isomer, prepared in Reference Example 19 , there were obtained 363 mg of almost pure title compound as white crystals.The crystals thus obtained were recrystallized from a mixture of ethyl acetate and cyclohexane 1 2 to give 285 mg of the title compound as white crystal having the same physical characteristics as those of the product prepared inReference Example 21. Reference Example 23 sE,13E 9a,11a,15a 6,9 methano 11,15 bis tetrahydro pyran 2 yloxy 15 cyclopentyl 16, 17,18 , 19, 20 pentanor prosta 5,13 dienoic acid methyl ester A mixture of 1.78 g of the almost pure 5E isomer prepared as described in Reference Example 19 5E.13E 9 alpha ,11 alpha ,15 alpha 6.9 methano 11,15 bis tetrahydro pyran 2 yloxy 15 cyclo pentyl 16,17,18,19,20 pentanor prosta 5,13 dienoic acid , 0.95 g of potassium carbonate, 1.07 ml of methyl iodide and 25 ml of acetone was refluxed gently for 1.5 hours. The reaction mixture was cooled and then concentrated under reduced pressure to one third the original volume of acetone.The residual solution thus obtained was diluted with ethyl acetate and washed with water, a saturated aqueous solution of ammonium chloride and a saturated aqueous solution sodium chloride, successively, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give 1.75 g of the title compound as crude product having the following physical characteristics TLC ethyl acetate cyclohexane 1 2 Rf 0.52 NMR 6 5.65 5.10 3H, m , 4.70 2H, m , 4.00 3.30 9H, m IR 9 1735, 1435, 1350, 1250, 1200, 1130, 1080, 1020, 980 cm Mass m e 428, 384, 344, 326, 300.Reference Example 24 5E,13E 9a,11a,15a 6,9 methano 11,15 dihydroxy 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid methyl ester A mixture of 1.75 g of the 11,15 bis tetrahydropyran 2 yloxy prosta 5,13 dienoic acid methyl ester compound prepared in Reference Example 23 , ca. 12 mg of p toluenesulphonic acid and 22 ml of methanol was stirred for 4 hours at room temperature. After addition of one ml of triethylamine, the reaction mixture was concentrated under reduced pressure. The residue was purified by column chromatography on silica gel eluent a mixture of ethyl acetate and cyclohexane, and ethyl acetate, successively to give 1.0 g of the title compound as white solid having the same physical characteristics as those of the product prepared inReference Example 14 a . Reference Example 25 5E,13E 9a,11a,15a 6,9 methano 11,15 dihydroxy 15 cyclopentyl 16,17,18,19,20 pentanorprosta 5,13 dienoic acid i.e. 5E l5 cyclopentyl l6,17,lS,19,20 pentanor 6, 9 methano PGI2 Proceeding as described in Reference Example 15, from 967 mg of the methyl ester compound prepared in Reference Example 24 , there were obtained 822 mg of the title compound having the same physical characteristics as those of the product prepared inReference Example 15.